SAAMP 2.0: An algorithm to predict genotype‐phenotype correlation of lysosomal storage diseases
Authors:
- 2 February 2018
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 93 (5) , 1008-1014
Abstract
Lysosomal storage diseases (LSDs) are a group of genetic disorders, resulting from deficiencies of lysosomal enzyme. Genotype‐phenotype correlation is essential for timely and proper treatment allocation. Recently, by integrating prediction outcomes of 7 bioinformatics tools, we developed a SAAMP algorithm to predict the impact of individual amino‐acid substitution. To optimize this approach, we evaluated the performance of these bioinformatics tools in a broad array of genes. PolyPhen and PROVEAN had the best performances, while SNP&GOs, PANTHER and I‐Mutant had the worst performances. Therefore, SAAMP 2.0 was developed by excluding 3 tools with worst performance, yielding a sensitivity of 94% and a specificity of 90%. To generalize the guideline to proteins without known structures, we built the three‐dimensional model of iduronate‐2‐sulfatase by homology modeling. Further, we investigated the phenotype severity of known disease‐causing mutations of the GLB1 gene, which lead to 2 LSDs (GM1 gangliosidosis and Morquio disease type B). Based on the previous literature and structural analysis, we associated these mutations with disease subtypes and proposed a theory to explain the complicated genotype‐phenotype correlation. Collectively, an updated guideline for phenotype prediction with SAAMP 2.0 was proposed, which will provide essential information for early diagnosis and proper treatment allocation, and they may be generalized to many monogenic diseases.Keywords
Funding Information
- National Institutes of Health (P01HD032652)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke
This publication has 19 references indexed in Scilit:
- Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I RegistryEuropean Journal of Pediatrics, 2012
- Crystal Structure of Human β-GalactosidaseJournal of Biological Chemistry, 2012
- GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findingsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profilingHuman Mutation, 2007
- Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate‐2‐sulfatase: Enzymatic activity, protein processing and structural analysisJournal of Inherited Metabolic Disease, 2006
- Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type IIJournal of Human Genetics, 2005
- Analysis of normal and mutant iduronate-2-sulphatase conformationBiochemical Journal, 2005
- Systematic Identification and Analysis of Exonic Splicing SilencersCell, 2004
- Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: Identification of 13 novel mutationsHuman Mutation, 2003
- Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure–function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like proteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999